Latest Breaking News On - Phospholipid drug conjugate - Page 1 : comparemela.com

Cellectar Biosciences and City of Hope Cancer Center Enter

Cellectar Biosciences and City of Hope Cancer Center Enter
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesOrange countySteven rosenCellectar biosciencesAndrei shustovStevent rosenClaire lacagninaLos angelesCity of hope cancer centerDrug administrationCancer centerBliss bio healthBeckman research institute of city hopeExchange commissionCellectar biosciences incNational cancer

Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides

Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Orange countyUnited statesAndrei shustovClaire lacagninaCellectar biosciencesStevent rosenLos angelesSteven rosenTranslational genomics research instituteExchange commissionGlobenewswire incPartnership withNational cancerDrug administrationCellectar biosciences incBliss bio health

Cellectar Biosciences Reports Financial Results for Q1 2024

Cellectar Biosciences Reports Financial Results for Q1 2024
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesJames carusoClaire lacagninaCellectar biosciencesExchange commissionNational institute of health cancerCellectar biosciences incAmerican oncology networkBliss bio healthDevelopment expenseRecent corporateFast trackNational instituteNational cancer instituteFlorida cancer specialistsCash equivalents

Cellectar Biosciences Reports Financial Results for Year

Management to host a conference call today at 8:30 am ET.

United statesJames carusoCellectar biosciencesClaire lacagninaDevelopment expenseBliss bio healthCellectar biosciences incExchange commissionRecent corporateRosalind advisorsCash equivalentsAdministrative expenseEastern timePhospholipid drug conjugateEnded decemberNasdaq clrb

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update

FLORHAM PARK, N.J., March 27, 2024 Cellectar Biosciences, Inc. , a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the.

United statesCellectar biosciencesJames carusoClaire lacagninaBliss bio healthCellectar biosciences incDevelopment expenseGlobenewswire incExchange commissionRecent corporateCash equivalentsAdministrative expenseEastern timePhospholipid drug conjugate